Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 16, 2021

View Archived Issues

New potent and selective USP7 inhibitor S-205474 presented

HTL-0041178 shows efficacy in models of psychosis and cognitive impairment

Base excision repairing may modulate susceptibility to Parkinson's disease

Gilead Sciences patents new antiviral compounds

Discovery of OXS-00005, a small-molecule candidate for regenerative medicine

Medshine Discovery synthesizes new RET inhibitors

Pharmasyntez JSC identifies HIV-1 reverse transcriptase/ribonuclease H inhibitors

Preclinical evidence supports delivery of HNF4A mRNA NPs to attenuate liver fibrosis and cirrhosis

Nurix Therapeutics and Gilead Sciences describe new PROTACs

SCN-16 targets the Keap1-Nrf2 protective pathway to treat ALI

MC-100093 attenuates cocaine relapse in rats

Oragenics evaluates SARS-CoV-2 vaccine candidate in hamster challenge study

Bayer gives details on discovery of IRAK-4 inhibitors BAY-845 and BAY-839

Chinese investigators divulge new recombinant fusion proteins

AbCellera and Moderna sign multitarget research collaboration and license agreement

RDT QuickStrip containing SARS-CoV-2 spike protein elicits immune response in animals

Blood-to-brain pathway may deliver amyloids in Alzheimer's disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...